Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00240149 · ClinicalTrials.gov registry record · NA

Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit

A NA study of Hyperglycemia, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
2
Study locations

NCT00240149 is a NA study of Hyperglycemia that has completed, run by Stanford University. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00240149, a NA study of Hyperglycemia, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
2
Study locations

Study Summary

Recent studies of adult intensive care unit (ICU) patients have shown significantly decreased morbidity and mortality when blood sugar concentrations are closely controlled. The safety and efficacy of this type of blood sugar management has not been studied in the pediatric ICU population. Based on the current pediatric literature data as well as our extensive retrospective study, blood sugar concentrations have a potentially profound role to play among PICU patients. In preparation for a multi-center randomized control trial, we propose a prospective feasibility study to evaluate the safety and effectiveness of using an insulin delivery algorithm to manage blood sugar in the PICU. Our hypothesis for this feasibility trial is that uniformly monitoring and controlling blood glucose with a Discrete-Closed-Loop(DCL) insulin delivery algorithm will be an effective, safe, and consistent means of delivering insulin to manage glucose in the pediatric intensive care unit.

Conditions Studied

Interventions

  • DRUG Regular Insulin via Insulin-Glucose Algorithm

Study Locations (2)

California

  • Lucile Packard Childrens Hospital - PICU - Stanford
  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Start Date 2005-10
Est. Completion 2006-03
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT00240149

The ClinicalTrials.gov registry entry for NCT00240149 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hyperglycemia appearing as the primary indexed condition, and to 1 intervention - of which Regular Insulin via Insulin-Glucose Algorithm is the first listed.

NCT00240149 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00240149 about?

NCT00240149 is a clinical study titled "Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit". Recent studies of adult intensive care unit (ICU) patients have shown significantly decreased morbidity and mortality when blood sugar concentrations are closely controlled. The safety and efficacy of this type of blood sugar management has not been studied in the pediatric ICU population. Based on ...

What is the current status of trial NCT00240149?

This trial is currently completed. It is a NA study. The study started on 2005-10. Estimated completion is 2006-03.

What conditions does trial NCT00240149 study?

This clinical trial studies the following conditions: Hyperglycemia.

What interventions are being tested in trial NCT00240149?

The interventions under investigation include: Regular Insulin via Insulin-Glucose Algorithm (DRUG).

Who is sponsoring clinical trial NCT00240149?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00240149 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.